These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 22730367)

  • 1. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires.
    Haroon M; Kirby B; FitzGerald O
    Ann Rheum Dis; 2013 May; 72(5):736-40. PubMed ID: 22730367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics.
    Mease PJ; Gladman DD; Helliwell P; Khraishi MM; Fuiman J; Bananis E; Alvarez D
    J Am Acad Dermatol; 2014 Oct; 71(4):649-55. PubMed ID: 24974240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study).
    Mishra S; Kancharla H; Dogra S; Sharma A
    Br J Dermatol; 2017 Mar; 176(3):765-770. PubMed ID: 27500901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study).
    Coates LC; Aslam T; Al Balushi F; Burden AD; Burden-Teh E; Caperon AR; Cerio R; Chattopadhyay C; Chinoy H; Goodfield MJ; Kay L; Kelly S; Kirkham BW; Lovell CR; Marzo-Ortega H; McHugh N; Murphy R; Reynolds NJ; Smith CH; Stewart EJ; Warren RB; Waxman R; Wilson HE; Helliwell PS
    Br J Dermatol; 2013 Apr; 168(4):802-7. PubMed ID: 23311587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis: A multicenter study.
    Cui R; Chen M; Li X; Wang Q; Tong Q; Zhang H; Chen Z; Tao YL; Bi XL; Deng H; Yuan DF; He DY; Ding YF; Dai SM
    J Dermatol; 2022 Jun; 49(6):615-623. PubMed ID: 35318711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Persian versions of two psoriatic arthritis screening questionnaires early arthritis for psoriatic patients questionnaire (EARP) and psoriasis epidemiology screening tool (PEST) in Iranian psoriatic patients.
    Lajevardi V; Ghodsi SZ; Shafiei M; Teimourpour A; Etesami I
    Turk J Med Sci; 2021 Feb; 51(1):159-166. PubMed ID: 32927935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires.
    Shin D; Kim HJ; Kim DS; Kim SM; Park JS; Park YB; Lee MG
    Rheumatol Int; 2016 Feb; 36(2):207-12. PubMed ID: 26395992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing the Thai Siriraj Psoriatic Arthritis Screening Tool and validating the Thai Psoriasis Epidemiology Screening Tool and the Early Arthritis for Psoriatic Patients questionnaire.
    Chiowchanwisawakit P; Wattanamongkolsil L; Srinonprasert V; Petcharat C; Siriwanarangsun P; Katchamart W
    Rheumatol Int; 2016 Oct; 36(10):1459-68. PubMed ID: 27333800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis.
    Walsh JA; Callis Duffin K; Krueger GG; Clegg DO
    J Rheumatol; 2013 Mar; 40(3):287-93. PubMed ID: 23378465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS).
    Gladman DD; Schentag CT; Tom BD; Chandran V; Brockbank J; Rosen C; Farewell VT
    Ann Rheum Dis; 2009 Apr; 68(4):497-501. PubMed ID: 18445625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.
    López Estebaránz JL; Zarco-Montejo P; Samaniego ML; García-Calvo C;
    Eur J Dermatol; 2015; 25(1):57-63. PubMed ID: 25333645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice.
    Spelman L; Su JC; Fernandez-Peñas P; Varigos GA; Cooper AJ; Baker CS; Lee M; Ring JM; Thirunavukkarasu K
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2184-91. PubMed ID: 26370225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Sinhala version of Psoriasis Epidemiology Screening Tool.
    Liyanage A; Verni S; Liyanage G; De Silva V; Akarawita J; Gunasekera C; Rubasinghe J; Imafuku S; Lekamwasam S
    Clin Rheumatol; 2021 Aug; 40(8):3127-3134. PubMed ID: 33594634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study.
    Henes JC; Ziupa E; Eisfelder M; Adamczyk A; Knaudt B; Jacobs F; Lux J; Schanz S; Fierlbeck G; Spira D; Horger M; Kanz L; Koetter I
    Rheumatol Int; 2014 Feb; 34(2):227-34. PubMed ID: 24114527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Toronto Psoriatic Arthritis Screen II (TOPAS II) questionnaire in a Turkish population.
    Duruöz MT; Şanal Toprak C; Ulutatar F
    Rheumatol Int; 2018 Feb; 38(2):255-259. PubMed ID: 29116441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis epidemiology screening tool (PEST) is useful for the detection of psoriatic arthritis in the Japanese population.
    Setoyama A; Sawada Y; Saito-Sasaki N; Ohmori S; Omoto D; Yamamoto K; Yoshioka H; Okada E; Nakamura M
    Sci Rep; 2021 Aug; 11(1):16146. PubMed ID: 34373544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of screening tools for psoriatic arthritis: a cross-sectional study in primary care.
    Karreman MC; Weel AEAM; van der Ven M; Vis M; Tchetverikov I; Nijsten TEC; Wakkee M; Hazes JMW; Luime JJ
    Rheumatology (Oxford); 2017 Apr; 56(4):597-602. PubMed ID: 28013202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Toronto Psoriatic Arthritis Screen II (ToPAS II) questionnaire in a Brazilian population.
    Gonçalves RSG; Pereira GA; de Andrade Lima E; Martins THF; Junior JOA; Carvalho JB; Mariz HA; Dantas AT; Duarte ALBP
    Clin Rheumatol; 2021 May; 40(5):1889-1892. PubMed ID: 33196983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'.
    Audureau E; Roux F; Lons Danic D; Bagot M; Cantagrel A; Dernis E; Gouyette N; Hilliquin P; Jullien D; Lioté F; Passeron T; A Richard M; Claudepierre P
    J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1950-1953. PubMed ID: 29430720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, short, and simple screening questionnaire can suggest presence of psoriatic arthritis in psoriasis patients in a dermatology clinic.
    Garg N; Truong B; Ku JH; Devere TS; Ehst BD; Blauvelt A; Deodhar AA
    Clin Rheumatol; 2015 Oct; 34(10):1745-51. PubMed ID: 24827874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.